Eversense 365 is said to be the world's first one-year CGM system, offering a new long-term solution for diabetes management.

Eversense 365 is a fully-implantable CGM with a 365-day sensor, making it the first 1-year CGM option for diabetes management ...

Continuous Glucose Monitoring (CGM) Systems Market The increasing incidence of diabetes and the detection of patient's blood glucose levels are raising the demand for continuous global monitoring ...

Senseonics (NYSE:SENS) announced today that it received FDA clearance for its next-generation Eversense 365 CGM system.

After collecting FDA green lights for 90- and 180-day versions, the agency has cleared the latest generation of the Eversense ...

Their research has been published in Science Advances, titled "Coin-sized, fully integrated, and minimally invasive ...

Eversense 365 cleared in the U.S. as an integrated continuous glucose monitoring (iCGM) system for people with diabetesWith a single sensor, the ...

has cleared the Eversense 365 continuous glucose monitoring (CGM) system for patients aged 18 years and older with type 1 or type 2 diabetes. Eversense ® 365 is a fully-implantable CGM with a 365 ...

Senseonics and Ascensia Diabetes Care have announced that the U.S. Food and Drug Administration has cleared the next-generation Eversense 365 CGM, the first one-year CGM system ...

Eversense 365 is claimed to be the world's first one-year CGM system, offering a new long-term solution for diabetes management. Eversense 365 is designed to support people with diabetes in ...